ADDF announces new awards through its Diagnostics Accelerator initiative

The Alzheimer's Drug Discovery Foundation (ADDF) announced six new investments totaling $6 million through its Diagnostics Accelerator initiative. These current awards include research for blood tests in various stages of development, with one close...

Amid Multi-Billion-Dollar Deals, Panels Highlight Gene Therapy Challenges

Murray Aitken, a senior VP with IQVIA and executive director of IQVIA’s Institute for Human Data Science. With multi-billion-dollar gene therapy merger-and-acquisition (M&A) deals bookending 2019, a panel of investors this week predicted more of...

Coaxial Electrospinning Creates New Platform for Treating Glioblastoma

Andrew Steckl, PhD, an Ohio eminent scholar and professor of electrical engineering in the University of Cincinnati’s (UC) college of engineering and applied science, working with researchers from Johns Hopkins University, said they have...

Dear Santa, I Want a Biotech Job for Christmas!

Hello biotechies, Job hunt frustration? Don’t worry, we’re here to help. Check out the offer from Immutep or become a Scientist at Genmab. Just starting out? Check out the internship at Bio Base Europe Pilot...

€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases

ImCheck Therapeutics has raised a Series B round worth €48M to fund the development of first-in-class immunotherapies that treat cancer and autoimmune diseases by targeting a rare type of immune cells called a gamma...

Water management grows farm profits

Credit: Jonathan Holt A healthy lifestyle consists of a mixture of habits. Diet, exercise, sleep and other factors all must be in balance. Similarly, a sustainable farm...

Hybrid antibiotics show promising results in eradicating deadly staph infections

Dec 4 2019 Eradicating deadly staph using a new breed of antibiotics has revealed promising results in research released by QUT, to help overcome one of the biggest modern medical challenges. The bacteria attach to medical...

Catalent Agrees to Manufacture BeiGene’s Tyrosine Kinase Inhibitor for Lymphoma Therapy

Catalent entered into a long-term commercial supply agreement with BeiGene, a biopharmaceutical company focused on developing and commercializing molecularly targeted and immuno-oncology drugs for the treatment of cancer. Catalent will manufacture BRUKINSA (zanubrutinib)], a...

Tuesday Sector Leaders: Precious Metals, Biotechnology Stocks – Nasdaq

In trading on Tuesday, precious metals shares were relative leaders, up on the day by about 2.8%. Leading the group were shares of Alexco Resources, up about 11.2% and shares of Harmony Gold Mining...

A window into evolution

Modelling the development of C4 photosynthesis Credit: Blätke / IPK Leibniz Institute Laboratory research is the possibly best-known driving force for advancement in science. However, when it comes...